Retraction notice to “Polo-like kinase 2 gene expression is regulated by the orphan nuclear receptor estrogen receptor-related receptor gamma (ERRγ)” ((Biochemical and Biophysical Research Communications (2007) 362(1) (107–113), (S0006291X07016622), (10.1016/j.bbrc.2007.07.170));Polo-like kinase 2 gene expression is regulated by the orphan nuclear receptor estrogen receptor-related receptor gamma (ERRγ)

Biochemical and Biophysical Research Communications

Volumn 362, Issue 1, 2007, Pages 107-113

  Park, Yun Yong ^a   Kim, Seok Ho ^b   Kim, Yong Joo ^c   Kim, Sun Yee ^d   Lee, Tae Hoon ^b   Lee, In Kyu ^d   Park, Seung Bum ^c   Choi, Hueng Sik ^a  

^a Chonnam National University   (South Korea)

^b Chonnam National University   (South Korea)

^c Seoul National University   (South Korea)

^d Kyungpook National University   (South Korea)

Author keywords

ERR ; Gene regulation; Plk2

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RELATED RECEPTOR GAMMA; POLO LIKE KINASE 2; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR GENE; TRANSCRIPTION INITIATION SITE;

EID: 34548072615     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2019.03.175     Document Type: Erratum

References (18)

1. Horard B., and Vanacker J.M. Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand. J. Mol. Endocrinol. 31 (2003) 349-357
2. Giguere V. To ERR in the estrogen pathway. Trends Endocrinol. Metab. 13 (2002) 220-225
3. Hong H., Yang L., and Stallcup M.R. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J. Biol. Chem. 274 (1999) 22618-22626
4. Greschik H., Wurtz J.M., Sanglier S., Burguet W., van Dorsselaer A., Moras D., and Renaud J.P. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol. Cell 9 (2002) 303-313
5. Tremblay G.B., Bergeron D., and Giguere V. 4-Hydroxytamoxifen is an isoform-specific inhibitor of orphan estrogen-receptor-related (ERR) nuclear receptors beta and gamma. Endocrinology 142 (2001) 4572-4575
6. Sanyal S., Kim J.Y., Kim H.J., Takeda J., Lee Y.K., Moore D.D., and Choi H.S. Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms. J. Biol. Chem. 277 (2002) 1739-1748
7. Park Y.Y., Ahn S.W., Kim H.J., Kim J.M., Lee I.K., Kang H., and Choi H.S. An autoregulatory loop controlling orphan nuclear receptor DAX-1 gene expression by orphan nuclear receptor ERRgamma. Nucleic Acids Res. 33 (2005) 6756-6768
8. Wang L., Liu J., Saha P., Huang J., Chan L., Spiegelman B., and Moore D.D. The orphan nuclear receptor SHP regulates PGC-1 alpha expression and energy production in brown adipocytes. Cell Metab. 2 (2005) 227-238
9. Liu D., Zhang Z., and Teng C.T. Estrogen-related receptor-gamma and peroxisome proliferator-activated receptor-gamma coactivator-1alpha regulate estrogen-related receptor-alpha gene expression via a conserved multi-hormone response element. J. Mol. Endocrinol. 34 (2005) 473-487
10. Zhang Z., Chen K., Shih J.C., and Teng C.T. Estrogen-related receptors-stimulated monoamine oxidase B promoter activity is down-regulated by estrogen receptors. Mol. Endocrinol. 20 (2006) 1547-1561
11. Zhang Y., Ma K., Sadana P., Chowdhury F., Gaillard S., Wang F., McDonnell D.P., Unterman T.G., Elam M.B., and Park E.A. Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J. Biol. Chem. 281 (2006) 39897-39906
12. Smith P., Syed N., and Crook T. Epigenetic inactivation implies a tumor suppressor function in hematologic malignancies for polo-like kinase 2 but not polo-like kinase 3. Cell Cycle 5 (2006) 1262-1264
13. Winkles J.A., and Alberts G.F. Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues. Oncogene 10 (2005) 260-266
14. Eckerdt F., Yuan J., and Strebhardt K. Polo-like kinases and oncogenesis. Oncogene 24 (2005) 267-276
15. Burns T.F., Fei P., Scata K.A., Dicker D.T., and El-Deiry W.S. Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells. Mol. Cell Biol. 23 (2003) 5556-5571
16. Syed N., Smith P., Sullivan A., Spender L.C., Dyer M., Karran L., O'Nions J., Allday J.M., Hoffmann I., Crawford D., Griffin B., Farrell J.P., and Crook T. Transcriptional silencing of polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies. Blood 107 (2006) 250-260
17. Warnke S., Kemmler S., Hames R.S., Tsai H.L., Hoffmann-Rohrer U., Fry A.M., and Hoffmann I. Polo-like kinase-2 is required for centriole duplication in mammalian cells. Curr. Biol. 14 (2004) 1200-1207
18. Choi Y.K., Kim Y.J., Park H.S., Choi K., Paik S.G., Lee Y.I., and Park J.G. Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney. Gene Ther. 10 (2003) 559-568